Riskpilot← Back to searchSign inGet full accessVyaire Medical AB
ABIn liquidationOrg 5590600671Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20160 employees
Revenue 2022
SEK 1,5M
EBITDA margin
37.2%
+1850% vs 2021
Equity ratio
31.4%
Financial strength
Net profit 2022
SEK -2K
+100% vs 2021
| Revenue | SEK 1,5M | — |
| EBITDA | SEK 546K | +1850% |
| Net profit | SEK -2K | +100% |
| Total assets | SEK 6,5M | -44% |
| Equity | SEK 2,1M | +0% |
| Employees | 0 | — |
Legal name
Vyaire Medical AB
Org number
5590600671
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
22 april 2016
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-09-30
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolagets verksamhet är att bedriva handel med medicinska produkter och tillbehör av diverse slag, samt tillhandahålla därmed relaterade tjänster. Vidare ska bolaget bedriva utveckling av och handel med programvara och därmed relaterade tjänster. Företaget kan också bedriva produktion av och handel med medicinska produkter och tillbehör för hemvård och tjänster relaterade därtill. För detta ändamål kan bolaget, i Sverige och utomlands, etablera filialer, medverka i andra företag som har ett identiskt eller relaterat ändamål, förvärva eller etablera liknande företag och i allmänhet vidta alla åtgärder och transaktioner som är lämpliga för att uppnå sitt syfte direkt eller indirekt. Dessutom kan företget också bevilja lån till närstående bolag och utföra andra aktiviteter med anknytning därtill.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 22 778 | 307 | 0 | 0 | 1 468 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 978 | −884 | 151 | 28 | 546 |
| Depreciation & amort. | −15 | −9 | −0 | −0 | −0 |
| EBIT | 963 | −893 | 151 | 28 | 546 |
| Net financials | −212 | −334 | 108 | −29 | −548 |
| Profit before tax | 751 | −1 227 | 259 | −1 | −2 |
| Tax | −180 | −82 | −0 | −400 | −0 |
| Net profit | 571 | −1 309 | 259 | −401 | −2 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 12 019 | 14 780 | 11 909 | 11 602 | 6 526 |
| Equity | 3 504 | 2 195 | 2 453 | 2 053 | 2 051 |
| Long-term debt | 1 403 | 0 | 0 | 0 | 0 |
| Short-term debt | 7 111 | 12 585 | 9 455 | 9 550 | 4 476 |
| Total debt | 8 514 | 12 585 | 9 455 | 9 550 | 4 476 |
EBITDA margin
37.2%
This company
15.8%
Market median
+135% vs market
20182022
Equity ratio
31.4%
This company
38.2%
Market median
+18% vs market
20182022
Return on equity
-0.1%
This company
18.4%
Market median
-101% vs market
20182022
Net profit margin
-0.1%
This company
8.1%
Market median
-101% vs market
20182022
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
20182022
Debt / equity
2.18×
This company
0.62×
Market median
-252% vs market
20182022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-10-01 – 2018-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SL Liquidator | Liquidator | 2025 |
| Former (2) | ||
BH Chief Auditor | Chief Auditor | 2020 – 2022 |
CM Authorized Recipient of Service | Authorized Recipient of Service | 2020 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (5) | ||
| Deputy Board Member | 2020 – 2025 | |
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2020 – 2021 | |
| Deputy Board Member | 2022 – 2023 | |
| Chairman | 2020 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vyaire Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Håkan Aspenblad | Chief Auditor | 0 companies |
| Carl Magnus Svernlöv | Authorized Recipient of Service | 0 companies |
| Sten Lennart Sjöstedt | Liquidator | 0 companies |
| Tom Ernst | Deputy Board Member | 0 companies |
| Timothy Stephen Fowler | Board of Directors | 0 companies |
| Kevin Mark Klemz | Deputy Board Member | 0 companies |
| John Elwood | Deputy Board Member | 0 companies |
| Nicholas William Throp | Chairman | 0 companies |